Nalaganje...
Silibinin ameliorates hepatic lipid accumulation and oxidative stress in mice with non-alcoholic steatohepatitis by regulating CFLAR-JNK pathway
Non-alcoholic steatohepatitis (NASH) is a chronic metabolic syndrome and the CFLAR-JNK pathway can reverse the process of NASH. Although silibinin is used for the treatment of NASH in clinical, its effect on CFLAR-JNK pathway in NASH remains unclear. This study aimed to investigate the effect of sil...
Shranjeno v:
| izdano v: | Acta Pharm Sin B |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Elsevier
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6664044/ https://ncbi.nlm.nih.gov/pubmed/31384535 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.apsb.2019.02.006 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|